Cytokinetics said on Tuesday its experimental heart disease drug significantly improved patients' ability to exercise compared to standard-of-care treatment in a late-stage study, sending shares of ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in ...

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

HONOLULU (AP) — Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and ...

Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.

Center at UCSF is pioneering the development of potent drug candidates aimed at preventing future coronavirus pandemics. Researchers at UC San Francisco and the Gladstone Institutes have developed new ...

CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA.

In a new book, Dr. Jerry Avorn says the changes being made to health agencies of the federal government could put patients at ...

The four anti-CD20 drugs used in the U.S. to treat relapsing MS -- ocrelizumab, ofatumumab, and ublituximab (Briumvi; ...

Founded in 2021, biotech start-up Ignota Labs wants to give promising but flawed drugs a new chance for market approval.